Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mehmet Asim Bilen"'
Autor:
Syed A. Hussain, Catherine Curran, Giuseppe Di Lorenzo, Ruby Gupta, Pasquale Verolino, Moshe Chaim Ornstein, Petros Grivas, Archana Agarwal, Mehmet Asim Bilen, Jorge A. Garcia, Guru Sonpavde, Alexandra Drakaki, Pedro C. Barata, Gregory R. Pond, Jae-Lyun Lee, Ravindran Kanesvaran
Publikováno v:
Clinical Genitourinary Cancer. 19:425-433
PD1/L1 inhibitors are approved by FDA as first-line therapy for patients with advanced urothelial carcinoma (aUC) who are cisplatin-ineligible with high tumor PD-L1 expression or are platinum-ineligible regardless of PD-L1 expression. However, the ou
Autor:
Yuan Liu, Julie M. Shabto, Bradley C. Carthon, Lauren Yantorni, Viraj A. Master, Dylan J. Martini, Omer Kucuk, Kenneth Ogan, Mehmet Asim Bilen, Shreyas S. Joshi, Jacqueline T. Brown, Deepak Ravindranathan, Wayne Harris, Sarah Caulfield, Haydn T. Kissick, Emilie Elise Hitron, Greta Russler
Publikováno v:
Oncologist
Background The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C-reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved fo
Autor:
Aristotelis Bamias, Vadim S. Koshkin, Victor Sacristan Santos, Matthew D. Galsky, Ana Fröbe, Joseph J. Park, David J. Pinato, Pedro Isaacsson Velho, Christopher J. Hoimes, Pavlos Msaouel, Jayanshu Jain, Daniel Castellano, Leonidas Nikolaos Diamantopoulos, Benjamin A. Gartrell, Neeraj Agarwal, Abhishek Tripathi, Ali Raza Khaki, Rafael Morales-Barrera, Ajjai Alva, Stepan M. Esagian, Lucia Carril-Ajuria, Jure Murgic, Tyler F. Stewart, Sandy T. Liu, Evan Shreck, Monika Joshi, Noah M. Hahn, Pedro C. Barata, Mehmet Asim Bilen, Lucia Alonso Buznego, Marcus Marie Moses, Ivan de Kouchkovsky, Vivek Kumar, Alexandra Drakaki, Yousef Zakharia, Ariel Ann Nelson, Roubini Zakopoulou, Petros Grivas, Evan Y. Yu, Alejo Rodriguez-Vida, Ignacio Duran, Alexander Sankin, Mark P. Lythgoe, Guru Sonpavde, Rana R. McKay, Michael Edward Devitt
Publikováno v:
BJU International. 128:196-205
Objectives: To compare clinical outcomes between patients with locally advanced (unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract receiving immune checkpoint inhibitors (ICIs). Patients and methods: We perfo
Autor:
Toni K. Choueiri, Amin Nassar, Pier Vitale Nuzzo, Marina D. Kaymakcalan, David A. Braun, Mehmet Asim Bilen, Sarah Abou-Alaiwi, Dylan J. Martini, John A. Steinharter, Ziad Bakouny, Justin H. Fleischer, Aly-Khan A. Lalani, Xiao X. Wei, Wanling Xie, Bradley Alexander McGregor, Lauren C. Harshman
Publikováno v:
European Journal of Cancer. 135:203-210
Background Cabozantinib is approved for the first and subsequent line treatment of metastatic clear-cell renal cell carcinoma (ccRCC) based on trials in which most patients were immune checkpoint blockade (ICB) naive. With an expanding role of ICB in
Autor:
Dimitrios Farmakiotis, Susie Owenby, Arturo Loaiza-Bonilla, Mansi R. Shah, Matthew Puc, Vadim S. Koshkin, Ahmad Daher, Prakash Peddi, Cameron Rink, Heloisa P. Soares, Eneida R. Nemecek, Mehmet Asim Bilen, Sanjay Mishra, Lidia Schapira, Amit Verma, Ali Raza Khaki, Chih-Yuan Hsu, Sandy DiLullo, Mark Bonnen, Jeanna Knoble, Carla Casulo, Umit Topaloglu, Jorge A. Garcia, Geoffrey Shouse, Praveen Vikas, Clarke A. Low, Archana Ajmera, George D. Demetri, Leyre Zubiri, Grace Glace, Shannon K. McWeeney, Susan Yackzan, Pamela C Egan, Rachel P. Rosovsky, Salvatore Del Prete, Anthony P. Gulati, Lane R. Rosen, Andy Futreal, Merry Jennifer Markham, Sabitha Prabhakaran, Alicia K. Morgans, Sarah Nagle, Lisa Weissmann, Albert C. Yeh, Ziad Bakouny, Stephanie Berg, David Gill, Marcus Messmer, Ryan Nguyen, Terence Duane Rhodes, Vikram M. Narayan, Matthew D. Galsky, Arielle Elkrief, Lori J. Rosenstein, Roy S. Herbst, Justin Shaya, Thorvardur R. Halfdanarson, Douglas B. Johnson, Orestis A. Panagiotou, Sanjay G. Revankar, Toni K. Choueiri, Yu Shyr, Fiona Busser, Kaitlin M. Kelleher, Nicole M. Kuderer, Paul L. Weinstein, Anup Kasi, Grace Shaw, Adam J. Olszewski, Catherine Curran, Samuel M. Rubinstein, Angelo Cabal, Michael H. Bar, John F. Deeken, Vivek Subbiah, Abdul Hai Mansoor, Hina Khan, Rana R. McKay, Catherine Stratton, Saurabh Dahiya, Marc A. Rovito, John Philip, Sanjay Shete, Oscar K. Serrano, Julie Fu, Daniel W. Bowles, Candice Schwartz, Tian Zhang, Pier Vitale Nuzzo, Eric H. Bernicker, Wenxin Xu, Genevieve M. Boland, Sarah Wall, Babar Bashir, Solange Peters, Neeta K. Venepalli, Sandeep H. Mashru, William A. Wood, Anne H. Angevine, Mary F. Mulcahy, Gilberto Lopes, Justin F. Gainor, Jessica Hawley, Monika Joshi, Christopher R. Friese, Navid Hafez, Heather H. Nelson, Gregory J. Riely, Jordan Kharofa, Nilo Azad, Chintan Shah, Gerald Batist, Mary Salazar, Rosemary Zacks, Alice Zhou, Lawrence E. Feldman, Paul Fu, Gary H. Lyman, Nathaniel Bouganim, John A. Steinharter, Shilpa Gupta, Matthias Weiss, Peter Paul Yu, Susan Van Loon, Jamie Stratton, Karen Vega-Luna, Tyler Masters, Christopher Lemmon, Aakash Desai, Bryan A. Faller, Jessica M. Clement, Zhuoer Xie, Keith Stockerl-Goldstein, Corrie A. Painter, Gabrielle Bouchard, Rulla M. Tamimi, Daruka Mahadevan, Rimma Belenkaya, Jill S. Barnholtz-Sloan, Jarushka Naidoo, Amelie G. Ramirez, Philip E. Lammers, Elizabeth A. Griffiths, Michael J. Gurley, X. Li, Jonathan Riess, Syed A. Ahmad, Daniel Blake Flora, Salma K. Jabbour, Jared D. Acoba, Neeraj Agarwal, Ang Li, Sarah Mushtaq, Firas Wehbe, Tanios Bekaii-Saab, Donald C. Vinh, Emily Hsu, Ryan Monahan, Petros Grivas, Harry Menon, John M. Nakayama, Janice M. Mehnert, Elizabeth Marie Wulff-Burchfield, Sara Matar, Paul E. Oberstein, Mary M. Pasquinelli, Axel Grothey, Jack West, John C. Leighton, Dawn L. Hershman, Leslie A. Fecher, Aditya Bardia, Sumit A. Shah, Barbara Logan, Kerry L. Reynolds, Michael A. Thompson, Robert L. Rice, Erin Cook, Trisha Wise-Draper, Christine Bestvina, Daniel Castellano, Paolo Caimi, K. M.Steve Lo, Ruben A. Mesa, Maheen Z. Abidi, Alvaro G. Menendez, Daniel G. Stover, Colleen Lewis, Bertrand Routy, Deborah B. Doroshow, Carmen C. Solorzano, M. Wasif Saif, Rohit Bishnoi, Michael Glover, David D. Chism, Briana Barrow, Christopher McNair, Dimpy P. Shah, Erin A. Gillaspie, Andrea J. Zimmer, Andrew Schmidt, Jessica K. Altman, Michelle Marcum, Rawad Elias, Balazs Halmos, Karen Stauffer, Gayathri Nagaraj, Ardaman Shergill, Mark E. Dailey, Catherine Handy Marshall, Pramod K. Srivastava, Shuchi Gulati, Alokkumar Jha, Mateo Bover Larroya, Mark A. Lewis, Young Soo Rho, James L. Chen, Eli Van Allen, Julie Tsu Yu Wu, Antonio Giordano, Amit Kulkarni, Joerg Rathmann, Donna R. Rivera, Narjust Duma, Maryam B. Lustberg, Theresa M. Carducci, Jeremy L. Warner, Elizabeth Robilotti, Patricia LoRusso, Rohit Jain, Amit Sanyal, Nizar M. Tannir, Kent Hoskins, Nathan A. Pennell, Brian I. Rini, Suki Subbiah
Publikováno v:
Lancet, vol. 395, no. 10241, pp. 1907-1918
The Lancet
The Lancet
Summary Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness. Methods In t
Autor:
Suresh S. Ramalingam, Conor E. Steuer, Mehmet Asim Bilen, Hannah Collins, Sagar Lonial, Zhengjia Chen, Bradley C. Carthon, Mehmet Akce, Olatunji B. Alese, Taofeek K. Owonikoko, Christina Wu, Ragini R Kudchagkar, David H. Lawson, R. Donald Harvey, Colleen Lewis, Chao Zhang, Bassel F. El-Rayes, Wayne Harris, Walid L. Shaib, Gabriel Sica, Fadlo R. Khuri
Publikováno v:
Clinical Cancer Research. 26:2497-2505
Purpose: Concurrent inhibition of mTOR and PI3K led to improved efficacy in preclinical models and provided the rationale for this phase I study of everolimus and buparlisib (BKM120) in patients with advanced solid tumor. Patients and Methods: We use
Autor:
Ziad Bakouny, Karen B Russell, Tomasz M. Beer, Chris Labaki, Chih-Yuan Hsu, Andrew Schmidt, Rana R. McKay, Benjamin A. Gartrell, Nima Sharifi, Sanjay Mishra, Ali Raza Khaki, John A. Steinharter, Neil J. Shah, Michael J. Morris, Cindy F Connell, Jay Zhu, Xin Gao, Elizabeth Marie Wulff-Burchfield, Tian Zhang, Matthew Puc, Shuchi Gulati, Matthew D Tucker, Justin Shaya, Brian I. Rini, Wenxin Xu, Yu Shyr, Petros Grivas, Harry Menon, Susan Halabi, Mehmet Asim Bilen, Shilpa Gupta, Clara Hwang, Toni K. Choueiri, Michael T. Schweizer, Ragneel R Bijjula, David Gill, Monika Joshi, Bryan A. Faller, Jeremy L. Warner, Andrew J. Armstrong, Scott J. Dawsey
Publikováno v:
JAMA Network Open
Key Points Question Given the higher COVID-19–related mortality rate observed among men than among women, is androgen deprivation therapy associated with decreased rate of 30-day mortality from COVID-19 among patients with prostate cancer? Findings
Autor:
Deepak Ravindranathan, T. S. Bekaii-Saab, Minh-Phuong Huynh-Le, Stephanie Berg, David Gill, C. Hennessy, Shuchi Gulati, Zhuoer Xie, Keith Stockerl-Goldstein, Ang Li, Clarke A. Low, D. Y. Reuben, Emily Hsu, Sharad Goyal, Petros Grivas, Chih-Yuan Hsu, D. J. Hausrath, Jessica Hawley, Harry Menon, Huili Zhu, A. Jayaraj, Barry Dixon, Rachel P. Rosovsky, Benjamin French, L. Tachiki, A. J. Piper-Vallillo, Dimitrios Farmakiotis, Daniel Kwon, Susan Halabi, Thorvardur R. Halfdanarson, Gary H. Lyman, Astha Thakkar, Arturo Loaiza-Bonilla, A. Fazio, Sumit A. Shah, Mehmet Asim Bilen, Michael A. Thompson, X. Li, Suki Subbiah, Matthias Weiss, Catherine Curran, E. Tadesse, Christopher McNair, Matthew Puc, Prakash Peddi, Corrie A. Painter, Ali Raza Khaki, Donna R. Rivera, Maryam B. Lustberg, Eric H. Bernicker, Vadim S. Koshkin, A. Nizam, M. Streckfuss, Alice Zhou, Aakash Desai, Sunny R K Singh, John M. Nakayama, Leslie A. Fecher, Samuel M. Rubinstein, Gd L. Lopes, Philip E. Lammers, Yu Shyr, Jaymin M. Patel, J. Crowell, Sanjay Mishra, Anup Kasi, Donald C. Vinh, Leyre Zubiri, Jeremy L. Warner, Nathan A. Pennell, V. Mico, Rana R. McKay, Amit Verma, M. E. Reeves, Daniel W. Bowles, Cathleen Park, Jared D. Acoba, David D. Chism, Gayathri Nagaraj, Matthew D. Galsky, Arielle Elkrief, M. Smits, Kripa Patel, N. L. Nock, Chinmay Jani, Clara Hwang, Mansi R. Shah, Angelo Cabal, Eric B. Durbin, Brian I. Rini, Peter Paul Yu, Tian Zhang, Dimpy P. Shah, M. Salazar, Shilpa Gupta, Lori J. Rosenstein, Christopher R. Friese, Gary K. Schwartz, Andrew Schmidt, Daniel Blake Flora, Justin Shaya, P. Bindal, D. Mundt, Julie Fu, Matthew D Tucker, Trisha Wise-Draper, Toni K. Choueiri, Deborah B. Doroshow, Rohit Bishnoi, E. Wulff-Burchfield, Balazs Halmos, Chintan Shah, Babar Bashir, Solange Peters, Nathaniel Bouganim, Paolo Caimi, Ruben A. Mesa, Maheen Z. Abidi, Daniel G. Stover, Nicole M. Kuderer, Michael Glover, Jia Wu, Punita Grover, Shirish M. Gadgeel, E. S. Nakasone, Douglas B. Johnson, Hina Khan, Ziad Bakouny
Publikováno v:
Annals of Oncology
BACKGROUND: Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-1
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background Combination regimens that include immune checkpoint (ICI) and vascular endothelial growth factor (VEGF) inhibition have opened the door to new treatment opportunities for patients with metastatic renal cell carcinoma (mRCC). While these tr
Autor:
Christina Wu, Dylan J. Martini, Walid L. Shaib, Mehmet Akce, Olatunji B. Alese, Yuan Liu, Joel P. Wedd, Mehmet Asim Bilen, Katerina Mary Zakka, Bassel F. El-Rayes, Amber Draper, Marty T. Sellers
Publikováno v:
American journal of clinical oncology. 44(2)
BACKGROUND Sarcopenia and inflammation are independently associated with worse survival in cancer patients. This study aims to determine the impact of sarcopenia, body mass index (BMI), and inflammatory biomarkers on survival in advanced hepatocellul